Prescribing Differences Among Older Adults with Differing Health Cover and Socioeconomic Status: a Cohort Study

Overview

Journal BMC Geriatr

Publisher Biomed Central

Specialty Geriatrics

Date 2023 Nov 18

PMID 37978448

Authors

Ciaran Prendergast

Michelle Flood

Logan T Murry

Barbara Clyne

Tom Fahey

Frank Moriarty

Affiliations

Soon will be listed here.

Abstract

Introduction: As health reforms move Ireland from a mixed public-private system toward universal healthcare, it is important to understand variations in prescribing practice for patients with differing health cover and socioeconomic status. This study aims to determine how prescribing patterns for patients aged ≥ 65 years in primary care in Ireland differ between patients with public and private health cover.

Methods: This was an observational study using anonymised data collected as part of a larger study from 44 general practices in Ireland (2011-2018). Data were extracted from electronic records relating to demographics and prescribing for patients aged ≥ 65 years. The cohort was divided between those with public health cover (via the General Medical Services (GMS) scheme) and those without. Standardised rates of prescribing were calculated for pre-specified drug classes. We also analysed the number of medications, polypharmacy, and trends over time between groups, using multilevel linear regression adjusting for age and sex, and hospitalisations.

Results: Overall, 42,456 individuals were included (56% female). Most were covered by the GMS scheme (62%, n = 26,490). The rate of prescribing in all drug classes was higher for GMS patients compared to non-GMS patients, with the greatest difference in benzodiazepine anxiolytics. The mean number of unique medications prescribed to GMS patients was 10.9 (SD 5.9), and 8.1 (SD 5.8) for non-GMS patients. The number of unique medications prescribed to both GMS and non-GMS cohorts increased over time. The increase was steeper in the GMS group where the mean number of medications prescribed increased by 0.67 medications/year. The rate of increase was 0.13 (95%CI 0.13, 0.14) medications/year lower for non-GMS patients, a statistically significant difference.

Conclusion: Our study found a significantly larger number of medications were prescribed to patients with public health cover, compared to those without. Increasing medication burden and polypharmacy among older adults may be accelerated for those of lower socioeconomic status. These findings may inform planning for moves towards universal health care, and this would provide an opportunity to evaluate the effect of expanding entitlement on prescribing and medications use.

Citing Articles

Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study.

De Clifford-Faugere G, Nguena Nguefack H, Menard N, Beaudoin S, Page M, Guenette L Front Pain Res (Lausanne). 2025; 6:1512878.

PMID: 40062205 PMC: 11885514. DOI: 10.3389/fpain.2025.1512878.

Out-of-pocket prescription medicine expenditure amongst community-dwelling adults: Findings from the Irish longitudinal study on ageing (TILDA) in 2016.

Larkin J, Prendergast C, Murry L, Flood M, Clyne B, Burke S Explor Res Clin Soc Pharm. 2025; 17:100565.

PMID: 39968511 PMC: 11833648. DOI: 10.1016/j.rcsop.2025.100565.

References

Murphy J, OKeeffe S . Frequency and appropriateness of antipsychotic medication use in older people in long-term care. Ir J Med Sci. 2008; 177(1):35-7. DOI: 10.1007/s11845-008-0121-7. View

Granlund D . Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?. Soc Sci Med. 2009; 69(11):1643-50. DOI: 10.1016/j.socscimed.2009.09.016. View

Hakansson A, Andersson H, Cars H, Melander A . Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care. Eur J Clin Pharmacol. 2001; 57(1):65-70. DOI: 10.1007/s002280100271. View

Ofori-Asenso R, Brhlikova P, Pollock A . Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015). BMC Public Health. 2016; 16:724. PMC: 4993007. DOI: 10.1186/s12889-016-3428-8. View

Basu S, Andrews J, Kishore S, Panjabi R, Stuckler D . Comparative performance of private and public healthcare systems in low- and middle-income countries: a systematic review. PLoS Med. 2012; 9(6):e1001244. PMC: 3378609. DOI: 10.1371/journal.pmed.1001244. View

OShea E . Male mortality differentials by socio-economic group in Ireland. Soc Sci Med. 1997; 45(6):803-9. DOI: 10.1016/s0277-9536(97)00037-3. View

Coll S, Walsh M, Fahey T, Moriarty F . Hospital initiation of benzodiazepines and Z-drugs in older adults and discontinuation in primary care. Res Social Adm Pharm. 2021; 18(4):2670-2674. DOI: 10.1016/j.sapharm.2021.06.001. View

Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T . The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015; 13:74. PMC: 4417329. DOI: 10.1186/s12916-015-0322-7. View

Pathirana T, Jackson C . Socioeconomic status and multimorbidity: a systematic review and meta-analysis. Aust N Z J Public Health. 2018; 42(2):186-194. DOI: 10.1111/1753-6405.12762. View

10.

Corsonello A, Pedone C, Corica F, Antonelli Incalzi R . Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag. 2008; 3(1):197-203. PMC: 1936300. DOI: 10.2147/tcrm.2007.3.1.197. View

11.

Himmel W, Kochen M, Sorns U, Hummers-Pradier E . Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther. 2004; 42(2):103-9. DOI: 10.5414/cpp42103. View

12.

. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995):743-800. PMC: 4561509. DOI: 10.1016/S0140-6736(15)60692-4. View

13.

Barnett K, Mercer S, Norbury M, Watt G, Wyke S, Guthrie B . Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380(9836):37-43. DOI: 10.1016/S0140-6736(12)60240-2. View

14.

Moriarty F, Hardy C, Bennett K, Smith S, Fahey T . Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015; 5(9):e008656. PMC: 4577876. DOI: 10.1136/bmjopen-2015-008656. View

15.

Perez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T . Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ. 2018; 363:k4524. PMC: 6233705. DOI: 10.1136/bmj.k4524. View

16.

Falster M, Charrier R, Pearson S, Buckley N, Daniels B . Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br J Clin Pharmacol. 2020; 87(3):1264-1274. DOI: 10.1111/bcp.14504. View

17.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4(10):e296. PMC: 2020495. DOI: 10.1371/journal.pmed.0040296. View

18.

Richardson K, Kenny R, Bennett K . The effect of free health care on polypharmacy: a comparison of propensity score methods and multivariable regression to account for confounding. Pharmacoepidemiol Drug Saf. 2014; 23(6):656-65. DOI: 10.1002/pds.3590. View

19.

Lam K, Miao Y, Steinman M . Cumulative changes in the use of long-term medications: a measure of prescribing complexity. JAMA Intern Med. 2013; 173(16):1546-7. PMC: 4081557. DOI: 10.1001/jamainternmed.2013.7060. View

20.

Covvey J, Johnson B, Elliott V, Malcolm W, Mullen A . An association between socioeconomic deprivation and primary care antibiotic prescribing in Scotland. J Antimicrob Chemother. 2013; 69(3):835-41. DOI: 10.1093/jac/dkt439. View